StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research note published on Saturday morning. The firm issued a hold rating on the stock.

China Pharma Price Performance

CPHI opened at $0.20 on Friday. The business has a fifty day moving average price of $0.23 and a 200 day moving average price of $0.24. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. China Pharma has a 12 month low of $0.17 and a 12 month high of $0.74.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.